<DOC>
	<DOC>NCT00159692</DOC>
	<brief_summary>To evaluate the percentage of subjects that reach the diabetic hypertensive blood pressure goal of &lt;130/80 with amlodipine versus placebo in subjects initially treated with quinapril or losartan.</brief_summary>
	<brief_title>Amlodipine Diabetic Hypertension Efficacy Response Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Documented evidence of Type 2 diabetes as defined by the ADA guidelines and documented evidence of Hypertension (various SBP/DBP ranges). A previous history or intolerance or hypersensitivity to calcium channel blockers, ARBs or ACE inhibitors.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>